Viewing Study NCT00502294


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-01-05 @ 3:43 PM
Study NCT ID: NCT00502294
Status: WITHDRAWN
Last Update Posted: 2009-06-25
First Post: 2007-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
Sponsor: Facet Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module